JP2024524374A5 - - Google Patents

Info

Publication number
JP2024524374A5
JP2024524374A5 JP2023580468A JP2023580468A JP2024524374A5 JP 2024524374 A5 JP2024524374 A5 JP 2024524374A5 JP 2023580468 A JP2023580468 A JP 2023580468A JP 2023580468 A JP2023580468 A JP 2023580468A JP 2024524374 A5 JP2024524374 A5 JP 2024524374A5
Authority
JP
Japan
Prior art keywords
slc9a3r2
seq
position corresponding
hypertension
uracil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023580468A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024524374A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/035712 external-priority patent/WO2023278694A1/en
Publication of JP2024524374A publication Critical patent/JP2024524374A/ja
Publication of JP2024524374A5 publication Critical patent/JP2024524374A5/ja
Pending legal-status Critical Current

Links

JP2023580468A 2021-07-02 2022-06-30 溶質輸送体ファミリー９アイソフォームａ３調節因子２（ｓｌｃ９ａ３ｒ２）阻害剤による高血圧症の治療 Pending JP2024524374A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163217909P 2021-07-02 2021-07-02
US63/217,909 2021-07-02
US202163221031P 2021-07-13 2021-07-13
US63/221,031 2021-07-13
PCT/US2022/035712 WO2023278694A1 (en) 2021-07-02 2022-06-30 Treatment of hypertension with solute carrier family 9 isoform a3 regulatory factor 2 (slc9a3r2) inhibitors

Publications (2)

Publication Number Publication Date
JP2024524374A JP2024524374A (ja) 2024-07-05
JP2024524374A5 true JP2024524374A5 (https=) 2025-06-23

Family

ID=82703151

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023580468A Pending JP2024524374A (ja) 2021-07-02 2022-06-30 溶質輸送体ファミリー９アイソフォームａ３調節因子２（ｓｌｃ９ａ３ｒ２）阻害剤による高血圧症の治療

Country Status (8)

Country Link
US (1) US20230027007A1 (https=)
EP (1) EP4363581A1 (https=)
JP (1) JP2024524374A (https=)
KR (1) KR20240029763A (https=)
AU (1) AU2022303368A1 (https=)
CA (1) CA3222828A1 (https=)
IL (1) IL309483A (https=)
WO (1) WO2023278694A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3093351B1 (en) * 2008-07-09 2018-04-18 Celera Corporation Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
CN115003800A (zh) * 2019-08-28 2022-09-02 安斯泰来再生医药协会 治疗血管疾病的方法

Similar Documents

Publication Publication Date Title
US11331290B2 (en) Niclosamide for the treatment of cancer metastasis
JP7030685B2 (ja) Ｄｃｒ３又はｄｃｒ３ネットワーク遺伝子に遺伝子変異を有する患者における自己免疫状態を治療する方法
ES2444695T3 (es) Polinucleótidos y polipéptidos implicados en el cáncer
NO315051B1 (no) Tumoravvisningsantigenforlöpere, tumoravvisningsantigener samt anvendelse derav
JPH08508402A (ja) 腫瘍拒絶抗原先駆体ｍａｇｅ‐３をコード化する分離された核酸分子とその利用
WO1995019367A1 (en) Screening assays for identifying agents that affect p53-dependent expression
US20100215637A1 (en) Agent for the Treatment of Hormone-Dependent Disorders and Uses Thereof
US20150299793A1 (en) Genetic Alterations on Chromosomes 21Q, 6Q and 15Q and Methods of Use Thereof for the Diagnosis and Treatment of Type 1 Diabetes
AU2002326409B2 (en) Method and reagents for identifying gene targets for treating breast cancer
WO2006014999A2 (en) Compositions and methods of use for modulators of nectin 4, semaphorin 4b, igsf9, and kiaa0152 in treating disease
JP2024524374A5 (https=)
US7994147B2 (en) Cellular genes regulated by HIV-1 infection and methods of use thereof
WO2003007793A2 (en) Compositions, methods, and kits related to treating and diagnosing hypertension
CA2387962A1 (en) A dna molecule encoding a variant .alpha.2b-adrenoceptor protein, and uses thereof
EP1368454A1 (en) Method for detecting a risk of hypertension and uses thereof
JP2024521224A5 (https=)
Sarkar et al. Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma
AU2001270058B2 (en) GP354 nucleic acids and polypeptides
US12186378B2 (en) Methods of treating skin cancer with histidine ammonia-lyase (HAL) agonists
US7462447B2 (en) Methods for evaluating susceptibility to a bone homeostasis disorder
WO2012034076A2 (en) Etv1 as a diagnostic, prognostic and therapeutic target for gastrointestinal stromal tumors
WO2002068466A2 (en) Hypoxia-regulated genes
US20230027007A1 (en) Treatment of Hypertension With Solute Carrier Family 9 Isoform A3 Regulatory Factor 2 (SLC9A3R2) Inhibitors
US20040115129A1 (en) Radiosensitivity enhancers in radiotherapy for cancer and nucleic acids and proteins enhancing radiosensitivity
NZ523477A (en) GP286 nucleic acids and polypeptides